PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026Cancer Medicine0 citationsOpen Access

Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021

View Full Paper
YCYuecan ChenYJYanjie JiangYXYehan Xu

Key Result

Non-Hodgkin Lymphoma significantly burdens middle-aged and elderly populations globally, requiring tailored interventions due to regional and demographic variations.

Key Points

  • The study aims to assess the global health burden of non-Hodgkin lymphoma (NHL) in middle-aged and elderly adults from 1990 to 2021.
  • Analyzed data from the Global Burden of Disease database.
  • Focused on variations by region, gender, and age group.
  • Conducted a systematic review of NHL prevalence and mortality.
  • Identified significant increases in NHL burden among middle-aged and elderly populations.
  • Noted variations in burden across different regions and demographics.
  • Highlighted the necessity for context-specific interventions to address disparities.

Structured PICO

P
Population
Middle-aged and elderly patients with Non-Hodgkin Lymphoma (NHL)
O
Outcome
Global public health burden

Highlights the significant and variable global public health burden of Non-Hodgkin Lymphoma in middle-aged and older adults from 1990 to 2021.

Abstract

NHL in middle-aged and older adults represents a significant global public health burden, necessitating context-specific interventions due to variations across regions, genders, and age groups.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2026) studied this question. Non-Hodgkin Lymphoma significantly burdens middle-aged and elderly populations globally, requiring tailored interventions due to regional and demographic variations.

synapsesocial.com/papers/69b3ac8102a1e69014cce335https://doi.org/10.1002/cam4.71609
Ask AI
Helpful
Bookmark
Share
View Full Paper